RESUMEvs22-Agatha Nolen

22
Agatha L. Nolen, Ph.D., D.Ph., FASHP 304 Pinnacle Pl Nashville, TN 37221 615-400-0611 EDUCATION: Tennessee State University Ph.D. August 2011 (Field of study: U.S. Health Policy) University of Oklahoma Graduate College M.S. May 1986 University of Oklahoma College of Pharmacy B.S. in Pharmacy May 1977 State University of New York at Geneseo Pre-Pharmacy/Chemistry Program 1972- 1974 WORK EXPERIENCE : April 2016 to present: Assistant Vice President, Pharmacy, Regulatory Compliance Support, HCA Corporate Offices, Nashville, Tennessee March 2006 to March 2016: Director, Regulatory Compliance Support, HCA Corporate Offices, Nashville, Tennessee February 2003 to March 2006: Director of Pharmacy, Centennial Medical Center, Nashville, Tennessee July 1997 to February 2003: Director of Pharmacy, Metropolitan Methodist Hospital/Northeast Methodist Hospitals (HCA joint venture), San Antonio, Texas Agatha L. Nolen, Ph.D., D.Ph., FASHP - 1 - 01/19/22

Transcript of RESUMEvs22-Agatha Nolen

Agatha L. Nolen, Ph.D., D.Ph., FASHP304 Pinnacle Pl

Nashville, TN 37221615-400-0611

EDUCATION:

Tennessee State UniversityPh.D. August 2011(Field of study: U.S. Health Policy)

University of Oklahoma Graduate CollegeM.S. May 1986

University of Oklahoma College of PharmacyB.S. in Pharmacy May 1977

State University of New York at GeneseoPre-Pharmacy/Chemistry Program 1972-1974

WORK EXPERIENCE:

April 2016 to present: Assistant Vice President, Pharmacy, Regulatory Compliance Support, HCA Corporate Offices, Nashville, Tennessee

March 2006 to March 2016: Director, Regulatory Compliance Support, HCA Corporate Offices, Nashville, Tennessee

February 2003 to March 2006: Director of Pharmacy, Centennial Medical Center, Nashville, Tennessee

July 1997 to February 2003: Director of Pharmacy, Metropolitan Methodist Hospital/Northeast Methodist Hospitals (HCA joint venture), San Antonio, Texas

May 1994 to July 1997: Director of Pharmacy, Baptist Medical Center, San Antonio, Texas

July 1990 to May 1994: Director of Pharmacy, Mercy Health Center, Oklahoma City, Oklahoma

December 1989 to July 1990: Manager of Pharmacy, Mercy Health Center, Oklahoma City, Oklahoma

Agatha L. Nolen, Ph.D., D.Ph., FASHP - 1 -05/01/23

November 1986 to December 1989: Charge Pharmacist, Surgery Pharmacy, St. Anthony Hospital, OKC, Oklahoma

January 1985 to November 1986: Staff Pharmacist, I.V. Room, St. Anthony Hospital, OKC, Oklahoma

May 1984 to January 1985: Staff Pharmacist, Oncology/Pulmonary Unit, St. Anthony Hospital, OKC, OK

May 1981 to May 1984: Coordinator, Critical Care Satellite Pharmacy, and Cardiovascular Research, University Hospital, OKC, OK

July 1979 to May 1981: Coordinator, I.V. Admixture Service, University Hospital, OKC, OK

August 1978 to July 1979: Staff Pharmacist, University Hospital, OKC, OK

January 1978 to December 1978: Author of Keeping Up section of Facts and Comparisons.

July 1977 to June 1978: Pharmacy Resident, Presbyterian Hospital, OKC, OK

FEDERAL AGENCY COMMITTEE APPOINTMENTS

Advisory Panel on Hospital Outpatient Payment 2016-2019

Ambulatory Payment Classification (APC) Panel 2007-2011(Federal Panel advises CMS on OPPS payment rates)Acting Chair, Data Subcommittee Feb 2011

PROFESSIONAL AFFILIATIONS:

Pi Alpha Alpha-National Honor Society for Public 2010-presentAffairs and Administration

Tennessee Pharmacists Association 2003-presentMember, Legislative and Regulatory Policy Committee 2006-presentMember, TSHP Legislative Committee 2016-presentMember, ad hoc Patient Care Continuum Committee 2006-2007

Tennessee Society of Hospital Pharmacists 2003-present

Texas Society of Hospital Pharmacists 1994-2003Member, Council on Organizational Goals and Strategic

Agatha L. Nolen, Ph.D., D.Ph., FASHP - 2 -05/01/23

Plan 1995-1996Vice-Chairman, Council on Professional Affairs 1996-2000Chairman, Council on Professional Affairs 2000-2001

American Society of Hospital Pharmacists 1976-presentASHP State Legislative Network 2014-presentASHP Pharmacy Leadership Academy Faculty 2007-2011Member, Center for Health-System Pharmacy

Leadership, Advisory Panel 2009-2011Member, Board of Directors 2004-2007Member, FASHP Recognition Committee 2007-2009Chairman, FASHP Recognition Committee 2010Member, Council on Administrative Affairs 2000-2003Member, ASHP Learning Community Design Team

On Patient Safety, Annual Meeting 2003 2002-2003Member, Selection Panel, ASHP Research &

Education Foundation, Patient Safety Grants 2002-2003Network Facilitator, Pharmacotherapy,

ASHP Section of Clinical Specialists 1998-1999Alternate, State Chapter Grants Selection Panel 1994-1995 ASHP Delegate 1986-1989

1992-1994Member, Committee on Nominations 1987-1988Member, Council on Organizational Affairs 1987-1989Chairman, Council on Organizational Affairs 1989-1990Member, SIG on Adult Clinical Practice 1987-1988Member, Review Panel for Contributed Papers,

Annual Meeting Jun 1979Program Coordinator, South Central Regional Clinical

Conference Mar 1987Member, Review Panel for Contributed Posters,

MCM Meeting Dec 1989Member, Review Panel for Contributed Posters,

Annual Meeting Jun 1990Coordinator, Project to rewrite ASHP Guidelines on

Investigational Drugs 1989-1990Member, Ad Hoc Technical Advisory Panel on the

Medicare Catastrophic Coverage Act 1989

Oklahoma Society of Hospital Pharmacists 1977-1995Legislative Committee 1990-1995President 1987-1988Secretary 1984-1986Membership Chairman 1979-1981Co-Editor, OSHP Newsletter 1979-1981

Oklahoma Pharmaceutical Association 1987-1995

Agatha L. Nolen, Ph.D., D.Ph., FASHP - 3 -05/01/23

Member, Legislative Committee 1989-1995Member, Hospital Pharmacists Committee 1992-1995

Central Texas Society of Health-System Pharmacists, member 1994-2003President-Elect 1996-1997President 1997-1998Immediate Past-President 1998-1999

American Heart Association, Member 1980-1994

CPR Instructor 1980-1987

American Mensa, Limited, Member 1984-1998

Task Force on Updating the Oklahoma Pharmacy PracticeAct, Member 1984-1993

Task Force on Updating the Oklahoma Pharmacy PracticeAct, Chairman 1991-1993

Oklahoma DHS SubCommittee on Cost-Containment, Member 1988-1990

Oklahoma Drug Utilization Review Board, Vice Chairman 1993-1994

MUSE (Medical User's Software Exchange) for MeditechComputer Users 1990-1994Region V Peer Group Leader 1991-1992International Information Officer 1993-1994

HSCA Advisory Committee (Buying Group) 1991-1994

Pharmacy Directors' Council, Sisters of Mercy-St. Louis,Chairman 1992-1994

Pharmaceutical Care Advisory Council (PCAC),Sisters of Mercy-St. Louis 1992-1994

OU College of Pharmacy Practicum AdvisoryBoard, Chairman 1993-1994

State Board of Pharmacy Technician Task Force on NewRegulations 1993-1994

Oklahoma Cancer Pain Initiative, Member 1993-1994

University of Texas Hospital Pharmacy Advisory Board 1995-1997

Agatha L. Nolen, Ph.D., D.Ph., FASHP - 4 -05/01/23

University of Texas Student Preceptor 1994-2003

Northwest Vista College, Pharmacy Technical Advisory Board 1995-2003Co-Chairman 2001-2003

UTSA Chip-In Club, Advisory Board for Golf Teams 2002-2003Chairman, Women’s Golf Team Advisory Board 2002-2003

FACULTY/TEACHING APPOINTMENTS:

University of Tennessee College of Pharmacy, Memphis, Assistant Professor 2005-presentDean’s Advisory Council 2008-2012

ASHP Pharmacy Leadership Academy FacultyModule 4: Leadership in Patient Safety and Quality 2007-2011

University of Houston College of Pharmacy, Houston, AdjunctFaculty 1998-2003

Northwest Vista College, San Antonio, Adjunct Faculty 1998-2003

Butler University, Indiana, Adjunct Faculty 1996-2003

University of Texas College of Pharmacy, Clinical Assistant Professor 1996-2003

University of Oklahoma College of Pharmacy, Clinical AssistantProfessor 1986-1994

Southwestern Oklahoma State University School of Pharmacy, ClinicalAssistant Professor 1989-1994

AWARDS AND OFFICES:

Innovative and Collaborative Practice Award, Texas Society ofHealth-System Pharmacists, 1999 Apr 1999

Fellow, American Society of Health-System Pharmacists Jan 1997

Outstanding Poster Award, TSHP Annual Seminar. Apr 1996

Bienfang Award, OU College of Pharmacy May 1990

Oklahoma Hospital Pharmacist of the Year May 1986Agatha L. Nolen, Ph.D., D.Ph., FASHP - 5 -05/01/23

University Hospital, Employee of the Month Dec 1979

John W. Dargavel Scholarship for Outstanding Professionalism May 1977S.Ph.A. Outstanding Service Award May 1977

Most Improved Women's Varsity Golfer 1976-1977

Regents Scholarship (New York State) 1972-1974

National Merit Letter of Commendation 1972

S.Ph.A. Secretary 1976-1977

Kappa Epsilon Chaplain 1976-1977

S.Ph.A. Public Relations Officer 1975-1976

EXTRA-CURRICULAR ACTIVITIES (College):

O.U. Women's Golf Team 1974-1976

Kappa Epsilon Professional Fraternity 1975-1977

Sooner Pharmaceutical Association 1974-1977

PERSONAL DATA:

Birthdate: 12-13-54Marital Status: Single

Agatha L. Nolen, Ph.D., D.Ph., FASHP - 6 -05/01/23

VOLUNTEER WORK:

St. George’s Episcopal Church, Vestry Member, Nashville, TN 2016-2018

Frist Center for Visual Arts, Nashville, TNVolunteer 2003-presentActive Certified Docent 2005-presentDocent Advisory Group 2011-2013

FedEx St. Jude Classic Annual Golf Tournament Volunteer 2014-present

Women’s Event- Minnie Pearl FoundationCo-Coordinator of Volunteers Sept 2010Co-Coordinator of Volunteers Sept 2011

Neighborhood Church Shepherd Leader, Holy Trinity CatholicChurch, San Antonio, TX 1997-1999

Neighborhood Parish Leader, Chimney Hill Association, St. John the Baptist Catholic Church, Edmond, OK 1993-1994

Variety Health Center, Coordinator of Pharmacy Services, Adult Medicine Clinic, OKC, OK 1983-1989

Good Shepherd Clinic, Pharmacy Director, First Baptist Church, OKC, OK 1981-1983

OTHER ACTIVITIES:

Expert Witness in Legal Cases on the Practice of Pharmacy 1990-present

Chapter Reviewer for ASHP Publication, PharmPrep 2001

Agatha L. Nolen, Ph.D., D.Ph., FASHP - 7 -05/01/23

PUBLICATIONS:

Books:

Nolen, A. (2012). Sailing Into The Wind: Ten Years of Public Policy in Health Reform to Improve Patient Safety with Health Information Technology, Cologne, Germany: LAMBERT Academic Publishing (LAP).

Articles:

1. “Valproic Acid: A New Antiepileptic Agent”: AL Gibney, Drug Information Bulletin, Presbyterian Hospital, Oklahoma City, Oklahoma, December 1977.

2. “Adverse Reactions of the Loop Diuretics: Ethacrynic Acid and Furosemide”: AL Gibney, Drug Information Bulletin, Presbyterian Hospital, Oklahoma City, Oklahoma, May 1978.

3. “Total Parenteral Nutrition-An Update”: G Parrish, AL Gibney, Drug Information Bulletin, Presbyterian Hospital, Oklahoma City, Oklahoma, March 1982.

4. “Total Parenteral Nutrition-An Update”: G Parrish, AL Gibney, L Ethel, Nutr Supp Serv 1982;2:3:9-17.

5. Determination of Drug Dosing of the Critically Ill Patient: TL Whitsett, AL Gibney. In: WH Massion, Ed., Progress in Critical Care Medicine. Switzerland, S. Karger-Basel, 1985:304-315.

6. “Dosage Adjustment of Cephalosporins in Renal Failure”: AL Gibney, Pharmacy Bulletin, St. Anthony Hospital, Oklahoma City, OK, April 1985.

7. “Are You a Pharm.D.?”: AL Gibney, Letter. Am J Hosp Pharm. 1985;42:2652,2660.

8. “Potentiation of Etomidate Anesthesia by Verapamil: A Report of Two Cases”: CA Moore, SF Hamilton, AL Underhill, L Fagraeus. Hosp Pharm 1989;24:24,25.

9. “Technician intervention in use of nonformulary agents in the surgical suite”: AL Underhill, CB Reno, FK Dougherty, Am J Hosp Pharm 1989;46:312-3.

10. “Expanded Technician Roles: Technician Involvement in the Quality Assurance Program in the Surgery Pharmacy”: J of Pharm Tech 1990;6:1:36-38.

11. Guidelines for the Administration of Emergency Medications, edited by GA Holt, AL Underhill. Published by Precept Press, 142 pages, 1991.

12. “Mercy Health Center Expands Surgery Pharmacy to ICU Patients”: A Carney, B Perdue, AL Underhill, C Woodland, OR Pharmacy Satellite Bulletin, Fall 1992, Vol VII;4:1-5.

Agatha L. Nolen, Ph.D., D.Ph., FASHP - 8 -05/01/23

13. “ A New Model in the Provision of Inpatient Pharmaceutical Care: The Admitting Pharmacist”: Nolen AL, Nester MA, Bhargava M, TSHP Journal, Spring/Summer 2001, Vol 2:1;11-15.

14. “Decreasing the Time to Administer First Dose Antibiotics on New Admissions by the Implementation of an Admitting Pharmacist Model of Pharmaceutical Care”: Nolen AL, Nester MA, Lauro M. TSHP Journal, October/December 2001, Vol. 2:3; 99-102.

15. “Using Medications Purchased in Mexico: Position Statement of the Texas Society of Health-System Pharmacists”: Nolen AL, Ball R, Pinon M, et al. Am J Health-Syst Pharm. 2002; 59:1289-90.

16. “Using Internal Supply Chain Experts”: Nolen AL, Kirkpatrick JM. Am J Health-Syst Pharm 2003; 60:2260-1.

17. “Implementing a Bar Coded Anesthesia Administration System for Improved Documentation and Patient Safety”: Nolen AL and Rodes WD. Pharm Purch & Prod 2007; Apr;22-4.

18. “Purchasing and Organization Tips for Anesthesia Trays”: Nolen AL. Pharm Purch & Prod 2007; May:8.

19. “Here Today, Gone Tomorrow! Dealing with Drug Shortages”: Nolen AL. In M. J. McNeil (Ed.), ASHP’s Safety and Quality Pearls. Bethesda, MD:Amer Society of Health-System Pharmacists, 2008; 115-21.

20. “Tennessee Legislators deserve full-time pay”: Nolen AL. Tennessean.com, 2008, March 28.

21. “Bar-code Medication Administration System for Anesthetics: Effects on Documentation and Billing”: Nolen AL and Rodes WD. Am J Health-Syst Pharm. 2008; 60:655-9.

PRESENTATIONS (STATEWIDE/NATIONAL/REGIONAL):

1. "Development of a Crash Cart Drug Tray for the Intensive and Coronary Care Units": AL Gibney, OSHP Annual Meeting, OKC, OK, May 1980.

2. "Cost-Effectiveness of a New Technique for Flushing Intra-vascular Pressure Monitoring Systems": AL Gibney, KC Nguyen, 19th Annual Midyear Clinical Meeting, Dallas, TX,December 1984.

3. "Relationship of Serum Concentration and Pharmacodynamic Response For Verapamil in Hypertensive Patients During Exercise": SF Hamilton, AL Gibney, U Thadani, 19th Annual

Midyear Meeting, Dallas Texas, December 1984.

Agatha L. Nolen, Ph.D., D.Ph., FASHP - 9 -05/01/23

4. "Cost-Effectiveness of a New Technique for Flushing Intra-vascular Pressure Monitoring Systems": AL Gibney, KC Nguyen, OSHP Annual Meeting, Western Hills State Lodge,

May 1985.

5. "Potentiation of Etomidate Anesthesia by Verapamil: A Report of Two Cases": CA Moore, SF Hamilton, AL Gibney, P Downs, L Fagraeus, 20th Annual Midyear Clinical Meeting,

New Orleans, LA, December 1985.

6. "Expanded Technician Roles: Antibiotic Formulary Control in the Surgery Pharmacy Through Technician Intervention": AL Gibney, CB Reno, FK Dougherty, 22nd Annual Midyear

Clinical Meeting, Atlanta, GA, December 1987.

7. "The Role of the Pharmacist on the Heart Transplant Team":AL Underhill, S Douglas, CB Frye, OSHP Annual Meeting, OKC, OK, May 1988.

8. “Labetalol-Induced Cardiac Abnormalities: A Report of Four Cases”: AL Underhill, CB Frye, OSHP Annual Meeting, OKC, OK, May 1988.

9. “OR Pharmacology”: AL Underhill, AORN Monthly Meeting, OKC, OK, October 1988.

10. “The Role of the Pharmacist on the Heart Transplant Team”: S Douglas, AL Underhill, CB Frye, ASHP Midyear Clinical Meeting, Dallas, TX, December 1988.

11. “Expanded Technician Roles: Technician Involvement in the Quality Assurance Program in the Surgery Pharmacy”: AL Underhill, CB Reno, FK Dougherty, CA Dreyling, ASHP Midyear Clinical Meeting, Dallas, TX, December 1988.

12. “Focused Review of Quality in a Pharmacokinetic Dosing Program”: C Crawley, D Anderson, CB Frye, C Dreyling, AL Underhill, ASHP Midyear Clinical Meeting, Atlanta, GA, December 1989.

13. “Investing in Students—Pharmacy’s Future: Strong Student Chapters”: AL Underhill, ASHP Annual Meeting, Boston, MA, June 1990.

14. “Q.A. in Antibiotics in Surgery”: AL Underhill, ASHP Midyear Clinical Meeting, Las Vegas, NV, December 1990.

15. “JCAHO: Testing the New Medication Use Indicators”: AL Underhill, OU C.E. Seminar, Lawton, McAlester, Enid and Ardmore on April 7 & 21, and September and October, 1991.

16. “Exposing Students to Hospital Pharmacy Through a Summer Learning Internship”: AL Underhill, S Allen, DW Lundquist, ASHP Annual Meeting, Washington, DC, June 1992.

17. “Moving from Q.A. to C.Q.I.: The Transformation of the Nursing/Pharmacy Task Force to the Medication Use CQI SubCommittee”: C Salem, AL Underhill, M Beavers, DW Lundquist, CL Nolen, ASHP Annual Meeting, Washington, DC, June 1992.

Agatha L. Nolen, Ph.D., D.Ph., FASHP - 10 -05/01/23

18. “Development and Implementation of a PC-based Database Program to Manage Membership Data for an ASHP Affiliated State Chapter”: MB St. Cyr, AL Underhill, and the Board of Directors, Oklahoma Society of Hospital Pharmacists, ASHP Annual Meeting, Washington, DC, June 1992.

19. “DUE/CQI”: Roche Management Seminars in Oklahoma City, Tulsa, Little Rock, Springdale, ARK, Ft. Smith, and Texarkana, TX, September 1992 to October 1993.

20. “Evaluating Antimicrobial Prophylaxis in Patients Exhibiting Surgical Wound Infections”: CE Woodland, AL Underhill, K Webb, R Pasley-Shaw, ASHP Midyear Clinical Meeting, Orlando, FL, December 1992.

21. “Mercy Pharmacy Ambulatory Services Follow-Up Program: An Opportunity to Enhance Pharmaceutical Care”: RM Lenhart, AL Underhill, PA Skaehill, ASHP Midyear Clinical Meeting, Orlando, FL, December 1992.

22. “Medicinal Leech Usage in the Treatment of Venous Congestion Following Digit Reimplantation Surgery”: LA Putt, L Lonsbury, D Noel, AL Underhill, ASHP Midyear Clinical Meeting, Orlando, FL, December 1992.

23. “Streamlining I.V. to P.O. Therapies”: AL Underhill, Southwest Medical Center, San Antonio, TX, Parkland Hospital, Dallas, TX, Abilene Regional Hospital, Abilene, TX, July to November, 1993.

24. “Changing I.V. to P.O. Therapy- A Workshop”: AL Underhill, Texas Society of Hospital Pharmacists Annual Meeting, San Antonio, TX, April 25 & 26, 1994.

25. “Involving Pharmacists in Direct Patient Care: A Compliance and Drug Knowledge Assessment Form”: AL Nolen, MJ Jariwala, KI Weisbrod, Texas Society of Hospital Pharmacists Annual Meeting, Dallas, TX, April 10, 1995.

26. “Assessing and Improving Outcomes of Care: A Mandate for Measuring and Monitoring Quality”: AL Nolen, Central Texas Society of Hospital Pharmacists Monthly Meeting, San Antonio, TX, August 8, 1995.

27. “Guidelines and Clinical Paths: Tools for Clinical Practice Improvement”: AL Nolen, Central Texas Society of Hospital Pharmacists Fall Seminar, Bandera, TX, October 28, 1995.

28. “Clinical Aspects of an I.V. to P.O. Streamline Program”: AL Nolen, Harris-Fort Worth Hospital System, Fort Worth, TX, November 15, 1995.

29. “Guidelines for Pharmacists in Documenting Medication Use to Enhance and Promote Pharmaceutical Care”: AL Nolen, MM Jariwala, TJ Patel, ASHP Midyear Clinical Meeting, Las Vegas, NV, December 1995.

30. “Involving Pharmacists in Direct Patient Care: Documenting Patient Compliance and Drug Knowledge Through Pharmacist Assessment: A Case Study”: AL Nolen, MM Jariwala, KI Weisbrod, ASHP Midyear Clinical Meeting, Las Vegas, NV, December 1995.

Agatha L. Nolen, Ph.D., D.Ph., FASHP - 11 -05/01/23

31. “Transitioning From Distributive to Clinical Services in 120 Days”: AL Nolen, MM Jariwala, TJ Patel, TSHP Annual Seminar, Corpus Christi, TX, April 1996.

32. “Testing a Pharmaceutical Care Model for Use by All Pharmacists for All Patients”: AL Nolen, MM Jariwala, TSHP Annual Seminar, Corpus Christi, TX, April 1996.

33. “Using Two Products to Reduce Costs in Our 3rd Generation Cephlosporin Formulary”: AL Nolen, MM Jariwala, TSHP Annual Seminar, Corpus Christi, TX, April 1996.

34. “Nonsteroidal Anti-inflammatory Drug Use in Heart Failure Patients”: PM Klem, AL Nolen, ASHP Midyear Meeting, New Orleans, LA, December 1996.

35. “Transitioning from Distributive to Clinical Services in 120 Days”: AL Nolen, MM Jariwala, TJ Patel, ASHP Midyear Meeting, New Orleans, LA, December 1996.

36. “Conversion from an IV Piggyback to IV Push Method of Antibiotic Administration: The Development, Implementation, and Associated Cost-savings”: MA Cantu, AL Nolen, BL Craddock, Alcalde XI, San Antonio, TX, March 1997.

37. “A Step-wise Approach to Improving Formulary Management”: N Lee, AL Nolen, TJ Patel, S Hendricks, Alcalde XI, San Antonio, TX, March 1997.

38. “Conversion from an IV Piggyback to IV Push Method of Antibiotic Administration: The Development, Implementation, and Associated Cost-savings”: MA Cantu, AL Nolen, BL Craddock, TSHP Annual Seminar, Austin, TX, April 1997.

39. “A Step-wise Approach to Improving Formulary Management”: N Lee, AL Nolen, TJ Patel, S Hendricks, TSHP Annual Seminar, Austin, TX, April 1997.

40. “Fostering Excellence: Statewide Clinical Skills Competition for Students and Practitioners”: LJ Danielski, AL Nolen, DB Ginsburg, ASHP Annual Meeting, Minneapolis, MN, June 1997.

41. “Financial Impact of a Pharmacist-Based Renal Dosing Program at Two Private Hospitals”: AL Nolen, MA Nester, SR Wirebaugh, OL Pineda, J Yau, J Snow, TSHP Annual Seminar, Houston, TX, April 1998.

42. “Planning, Implementation, and Follow-up for an Invitational Conference on Identifying, Resolving, and Preventing Medication Mis-adventures in Our Community”: AL Nolen, and the Central Texas Society of Health System Pharmacists Board of Directors, TSHP Annual Seminar, Dallas, TX, April 1999.

43. “The Admitting Pharmacist: Implementing a New Model for the Provision of Inpatient Pharmaceutical Care”: MA Nester, AL Nolen, M Bhargava, TSHP Annual Seminar, Dallas, TX, April 1999.

Agatha L. Nolen, Ph.D., D.Ph., FASHP - 12 -05/01/23

44. “Decreasing the Time to Administer First Dose Antibiotics on New Admissions by the Implementation of an Admitting Pharmacist Model of Pharmaceutical Care”: AL Nolen, MA Nester, M Bhargava, TSHP Annual Seminar, Dallas, TX, April 1999.

45. “The Impact of an Infectious Disease Pharmacist on Antibiotic Costs”: SM Grasso, AL Nolen, MA Nester, OL Pineda”, TSHP Annual Seminar, Dallas, TX, April 1999.

46.”Atrial Fibrillation: Optimizing Anticoagulation Therapy for Stroke Prevention”: MM Siech, AL Nolen, SR Wirebaugh, TSHP Annual Seminar, Dallas, TX, April 1999.

47. “Measuring, Monitoring, and Improving Sedation Care Outcomes”, Roche Skills Development Seminar, Houston, TX, September 25, 1999.

48. “Measuring, Monitoring, and Improving Sedation Care Outcomes”, Roche Skills Development Seminar, Galveston, TX, October 19, 1999.

49. “Pharmacy Process Improvements by the Pharmacy Admitting Team”, Quality 2000-1st Annual Quality Symposium, University Health System, San Antonio, TX, October 22, 1999.

50. “Measuring, Monitoring, and Improving Sedation Care Outcomes”, Roche Skills Development Seminar, San Antonio, TX, October 23, 1999.

51. “Pharmacy Practice Residencies”, UTSSHP Student Society Meeting, University of Texas, Austin, TX, November 4, 1999.

52. “Pharmacy Practice Residencies”, Texas Tech University, Amarillo, TX, April 29, 2002.

53. “Pharmaceuticals and Barcoding”, panel discussion, American Hospital Association Press Conference announcing the National Alliance for Information Technology, Washington, DC, June 25, 2002.

54. “Barcodes and Pharmaceuticals: What It Means for the Future of Patient Safety and Medical/Surgical Supplies”, Association for Healthcare Resource & Materials Management 40th Annual Conference & Exhibition, San Antonio, TX, August 8, 2002.

55. “eMAR and Barcoding: Panel Discussion”, participant, HCA National Pharmacy Directors Meeting, Nashville, TN, October 14-16, 2002.

56. “Patient Safety Initiatives-Roundtable Discussions”, HPG/PACT Annual Pharmacy Meeting, Atlanta, GA, December 8, 2002.

57. “Unexpected Issues of Implementing Bar Codes Systems-Pharmacy Manager’s Networking Forum”, ASHP Midyear Meeting, Atlanta, GA, December 11, 2002.

58. “Implementing Electronic Medication Administration Records and Barcoding”, ASHP Midyear Meeting, Atlanta, GA, December 11, 2002.

Agatha L. Nolen, Ph.D., D.Ph., FASHP - 13 -05/01/23

59. “Learning Community: Medication Safety: A Practical Approach to FMEA and RCA”, Design Team member and faculty, ASHP Summer Meeting, San Diego, CA, June 2-4, 2003.

60. “Here Today, Gone Tomorrow-Dealing with Drug Shortages”, Safety and Quality Pearls 2006, ASHP Midyear Clinical Meeting, Anaheim, CA, Dec 4, 2006.

61. “An Analysis of the Food and Drug Administration Decision to Move Orlistat from Prescription to Over-the-Counter status”, Southeast Conference of Public Administration (SECoPA), Nashville, TN, Sept 28, 2007.

62. “Organizational Characteristics of Pharmaceutical Manufacturers as Predictors of Fulfillment of Food and Drug Administration Post Marketing Commitments”, Southeast Conference of Public Administration (SECoPA), Nashville, TN, Sept 28, 2007.

63. “Complexities and Compliance and the CDM”, ASHP 44th Midyear Meeting, Las Vegas, NV, December 9, 2009.

64. “The 2011 Changes to Medicare Reimbursement and Requirements to Ensure Compliance”, ASHP 45th Midyear Meeting, Anaheim, CA, December 8, 2010.

MASTER'S RESEARCH:

"Acute Dose-Pharmacodynamic Response Relationship For Verapamil in Hypertensive Patients During Exercise"

Ph.D. RESEARCH:

“Barriers to Reforming the U.S. Health Care System for Patient Safety: A Study of Ten Years of Policy Implementation for Three Health Information Technology (HIT) Strategies”

Agatha L. Nolen, Ph.D., D.Ph., FASHP - 14 -05/01/23